WSL
BVS icon

Western Standard LLC’s Bioventus BVS Stock Holding History

Western Standard LLC’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-281,413
Closed -$929K – 32
2023
Q3 		$929K Sell
281,413
-114,903
-29% -$403K 0.84% 22
2023
Q2 		$1.15M Buy
+396,316
New +$761K 0.99% 18

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Western Standard LLC's BVS Position: Q4 2023 in Review

Western Standard LLC sold out of Bioventus (BVS) in Q4 2023, closing a stake of 281,413 shares — an estimated $929K sold.

Western Standard LLC first reported a position in BVS in Q2 2023 and held it in 2 quarters. The position peaked at $1.15M in Q2 2023. 80 funds tracked by Wall St. Rank hold BVS as of Q4 2023.

  • Western Standard LLC reported no remaining Bioventus position as of Q4 2023 after selling out during the quarter.
  • Western Standard LLC sold 281,413 Bioventus shares in Q4 2023, an estimated $929K.
  • Western Standard LLC first reported a position in Bioventus in Q2 2023 and held it in 2 quarters.
  • Western Standard LLC's Bioventus position peaked at $1.15M in Q2 2023.
  • 80 funds tracked by Wall St. Rank held Bioventus as of Q4 2023.

Based on Western Standard LLC's 13F filing for Q4 2023, filed 14 Feb 2024.